News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals to Participate in Three Investor Conferences in May 2021

May 04, 2021

DUBLIN, May 4, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and financial updates at the following virtual investor conferences:

  • BofA Securities 2021 Health Care Conference on Tuesday, May 11, 2021 at 1:15 p.m. ET / 6:15 p.m. IST
  • RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021 at 10:40 a.m. ET / 3:40 p.m. IST
  • UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 11:00 a.m. ET / 4:00 p.m. IST

Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at A replay of the webcast will be archived on the website for at least one week.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing life-changing medicines for people with serious diseases — often with limited or no options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. Our focus is in neuroscience, including sleep medicine and movement disorders, and in oncology, including hematologic malignancies and solid tumors. We actively explore new options for patients including novel compounds, small molecules, biologics and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in more than 90 countries. For more information, please visit and follow @JazzPharma on Twitter.

Jazz Pharmaceuticals Contacts:

Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Ireland +353 1 63 43211

Jacqueline Kirby
Vice President, Corporate Affairs & Government Relations  
Ireland +353 1 697 2141
U.S. +1 215 867 4910


Jazz Pharmaceuticals Logo (PRNewsFoto/Jazz Pharmaceuticals plc) (PRNewsFoto/Jazz Pharmaceuticals plc)


Cision View original content to download multimedia:

SOURCE Jazz Pharmaceuticals plc